Mathematical models Optimizing treatment

This group develops and applies mathematical models describing clinical pharmacology processes to interpret clinical trial data, perform clinical trial simulations, support drug development decisions, and optimize therapy in the clinic.

Aims

Our group has several aims. For example the aim to maximize the impact of research through the use of model-based analyses.

read more

Aims

  • To maximize impact of research by making optimal use of preclinical information and longitudinal clinical data through model-based analyses.
  • To facilitate use of advanced pharmacometric methodology in clinical care.
  • To support other research groups with population pharmacokinetic-pharmacodynamic data analysis and physiologically based mechanistic modeling.
  • To be a center of excellence in pharmacometrics and to train the next generation of researchers.

Research group leader

Rob ter Heine PhD
postdoc

+31 (0)24 361 64 05
contact

Research group leader

Elin Svensson PhD
postdoc

+31 (0)24 309 25 95
contact

Team

Related research groups


Research group Mycobacterio­logy

Jakko van Ingen's research group aims to improve the outcomes of antibiotic treatment of NTM disease.

read more

Research group Pharmacology of antiviral drugs (HIV and HCV)

David Burger's group investigates the pharmacology of antiviral drugs for the treatment of HIV and hepatitis C in special patient population such as pregnant women, children and hepatically impaired patients. We also study drug-drug interactions and the impact on exposure of new drug-formulations.

read more

Research group Pharmacology of anti-tuberculosis drugs

Rob Aarnoutse's research group investigates the pharmacology of existing and new drugs for tuberculosis, using a translational approach that extends from molecular pharmacology to clinical pharmacology studies and to clinical trials, supported by advanced laboratory and modeling techniques.

read more

Radboud Institute for Health Sciences

Ideally, every procedure in clinical practice and public health should take place based on proof, instead of intuition or 'experience'. Our aim is to innovate and personalize healthcare and public health. read more